These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35290756)

  • 21. Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients.
    Plūme J; Galvanovskis A; Šmite S; Romanchikova N; Zayakin P; Linē A
    J Transl Med; 2022 Apr; 20(1):176. PubMed ID: 35428263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
    Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens.
    Rezaei M; Sadeghi M; Korourian A; Tabarsi P; Porabdollah M; Askari E; Mortaz E; Mahmoudi S; Marjani M; Velayati AA
    Hum Antibodies; 2021; 29(2):109-113. PubMed ID: 33720878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
    Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
    Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Lynch KL; Whitman JD; Lacanienta NP; Beckerdite EW; Kastner SA; Shy BR; Goldgof GM; Levine AG; Bapat SP; Stramer SL; Esensten JH; Hightower AW; Bern C; Wu AHB
    Clin Infect Dis; 2021 Jan; 72(2):301-308. PubMed ID: 33501951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of lateral flow and ELISA techniques for detecting IgG and IgM antibodies in COVID-19 cases in Türkiye.
    Arikan A; Doluca O; Akhan S; Sanlidag T; Sayan M
    East Mediterr Health J; 2023 Feb; 29(2):91-99. PubMed ID: 36880490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
    Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
    Front Immunol; 2021; 12():723585. PubMed ID: 34489974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L
    Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between IgG and IgM levels and severity of symptoms in COVID-19 patients confirmed by rapid antigen test.
    Al-Ibraheemi JSS; Al-Saeedi AS
    J Med Life; 2021; 14(6):790-796. PubMed ID: 35126749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial.
    Ren L; Fan G; Wu W; Guo L; Wang Y; Li X; Wang C; Gu X; Li C; Wang Y; Wang G; Zhou F; Liu Z; Ge Q; Zhang Y; Li H; Zhang L; Xu J; Wang C; Wang J; Cao B
    Clin Infect Dis; 2021 May; 72(10):e545-e551. PubMed ID: 32840287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
    Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B
    Front Immunol; 2021; 12():614436. PubMed ID: 33790892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections.
    Luo J; Brakel A; Krizsan A; Ludwig T; Mötzing M; Volke D; Lakowa N; Grünewald T; Lehmann C; Wolf J; Borte S; Milkovska-Stamenova S; Gabert J; Fingas F; Scholz M; Hoffmann R
    Virol J; 2022 Mar; 19(1):50. PubMed ID: 35305688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
    Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T
    Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.